Skip to main content
Signal8

BRATTON DOUGLAS K

SEC insider (Form 3/4/5 filer). CIK 0001281933. 10% Owner at Aquestive Therapeutics, Inc. (AQST). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 2, 2024. Located in FORT WORTH, TX.

Companies BRATTON DOUGLAS K has filed insider reports for

  • Aquestive Therapeutics, Inc. (AQST): 10% Owner
BRATTON DOUGLAS K profile photo

BRATTON DOUGLAS K

CIK: 0001281933

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aquestive Therapeutics, Inc. logo
AQST

Aquestive Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Dec 2, 2024
    Gift
    Indirect
    40K shares-

1-1 of 1